Close MenuClose
Close Menu
Keith J . Christensen, PharmD, BCPS

Associate Professor

Keith Christensen

Contact

School of Pharmacy and Health Professions
Pharmacy
Pharmacy Faculty
Pharmacy Practice
Faculty - Pharmacy, OT, PT
HLSB - Hixson Lied Science Building

Keith J . Christensen, PharmD, BCPS

Associate Professor

Department

Pharmacy Practice

Position

Associate Professor

Books

  • Journal of Doctoral Nursing Practice
    Christensen KJ. Chapter 66 - Medical Drugs and Their Effect on Sleep and Wakefulness. In Lee-Chiong TL, Sateia MJ, Carskadon MA (eds): Sleep Medicine. Philadelphia, Hanley & Belfus 2001

Articles

  • Annals of Pharmacotherapy
    Brown, Jack E., Fominaya, Cory, Christensen, Keith J., McConnell, Scott A., Lamp, Kenneth C. Daptomycin Experience in Critical Care Patients: Results from a Registry
    46, p. 495-502 2012
  • Annals of Pharmacotherapy
    Brown J, Cory F, Christensen KJ, McConnell SA, Lamp KC. Daptomycin Experience in Critical Care Patients: Results from a Registry.
    46, p. 495-502 2012
  • BMC infectious diseases
    Destache, C. J., Belgum, T., Christensen, K., Shibata, A., Sharma, A., Dash, A. Combination antiretroviral drugs in PLGA nanoparticle for HIV-1
    9, p. 198 2009
  • Infectious Diseases
    Destache CJ, Belgum T, Christensen KJ, Shibata A, Sharma A, Dash A. Combination antiretroviral drugs in PLGA nanoparticle for HIV-1.
    9, p. 198-205 2009
  • American Journal of Critical Care
    Malesker, M. A., Foral, P. A., McPhillips, A. C., Christensen, K. J., Chang, J. A., Hilleman, D. E. An efficiency evaluation of protocols for tight glycemic control in intensive care units
    16, p. 589-598 2007
  • American Journal of Critical Care
    Malesker MA, Foral PA, Christensen KJ, Hilleman DE. An efficiency evaluation of tight glycemic control protocols in the intensive care unit.
    16, p. 589-598 2007
  • American Journal of Pharmaceutical Education
    Monaghan MS, Jones RM, Faculty Case Writing Teams (Christensen K). Designing an assessment for an abilities-based curriculum; process reliability of the first two years.
    69(2), p. Article 19 2005
  • Journal of Doctoral Nursing Practice
    Christensen KJ. Drotrecogin alfa (activated). UHC/Novation Drug Monograph. 2001
  • Journal of Doctoral Nursing Practice
    Christensen KJ. Dexmedetomidine. UHC/Novation Drug Monograph. 2000
  • American Journal of Hospital Pharmacists
    Christensen KJ, Gubbins PO, Gurley BJ, Bowman JL, Buice RG. Relative bioavailability of itraconazole from an extemporaneously prepared suspension and the marketed capsule.
    55, p. 261-265 1998
  • Journal of Doctoral Nursing Practice
    Christensen KJ, Gubbins PO. Treatment of vancomycin-resistant staphylococcal infections.
    30, p. 228-232 1996

Publications

  • American Journal of Pharmaceutical Education
    Christensen KJ, Monaghan MS, Walters RW, Chapman T. Delivery Preference and Student Perception of Lecture Capture Impact In A Doctor of Pharmacy Curriculum.
    77(5), p. 61 2013
  • American Journal of Pharmaceutical Education
    Christensen KJ. Evidence of Potential Deficiency in Longitudinal Learning: Revisiting Pharmacy Calculations.
    77(5), p. 68 2013
  • ASHP Midyear Clinical Meeting
    Shafer DW, Christensen KJ, Friedman S. Evaluation of aminoglycoside (gentamicin and tobramycin) use, dosing method, and monitoring in an academic medical center versus a private institution.
    7, p. 125 2012
  • American Journal of Pharmaceutical Education
    Christensen KJ, Pick AM. Utilization of pharmacy residents as pharmacotherapeutics case study coordinators.
    74(5), p. 96 2010
  • ASHP Midyear Clinical Meeting
    Anthone JA, Christensen KJ. Changes in heart rate following multiple-dose therapy with inhaled beta-2 agonists in hospitalized patients., p. 44 2009
  • American Journal of Pharmaceutical Education
    Elsasser GN, Christensen KJ, Spangler M, Clark B, Davis R, Young WW. Facilitating distance student participation on a pharmacy admission committee via web-cam technology.
    73(4), p. 57 2009
  • American Journal of Pharmaceutical Education
    Christensen KJ, Malesker MA, Ryan-Haddad AM, Poepping-Faulkner MA, Hoie EB. Enhancing therapeutics case study student performance following lab restructure.
    73(4), p. 57 2009
  • Critical Care Medicine
    McConnell SA, Christensen KJ, Patel H, White P. Daptomycin use in critically ill patients with sepsis and MRSA bacteremia.
    37(12), p. 857 2009
  • Conference on Retroviruses and Opportunistic Infections
    11. Destache C, Belgum T, Elsasser G, Christensen K, Shibata A. Ritonavir-, Lopinavir-, and Efavirenz-containing Nanoparticles: in vitro release of ART. CROI 2008 – 15th Conference on Retroviruses and Opportunistic Infections, p. 743 2008
  • Critical Care Medicine
    Christensen KJ, McConnell SA, Lamp KC, Brown J. Daptomycin use in critical care patients with sepsis.
    36(12), p. 618 2008
  • Pharmacotherapy
    Christensen KJ, McConnell SA, Brown J, Lamp KC. Daptomycin use in patients with sepsis.
    28, p. 151e 2008
  • ASHP Midyear Clinical Meeting
    Foral PA, Malesker MA, Hilleman DE, Christensen KJ, McPhillips A. Nursing satisfaction survey concerning tight glycemic control protocols in the ICU. ASHP Midyear Clinical Meeting, p. 42 2007
  • ASHP Midyear Clinical Meeting
    Malesker MA, Chang JA, Foral PA, Hilleman DE, Christensen KJ. Analysis of variations in a tight glycemic control protocol. ASHP Midyear Clinical Meeting , p. 41 2006
  • Pharmacotherapy
    McConnell SA, Amsden JR, Christensen KJ. 2004 ACCP-Amgen Hematology/Oncology Investigators Development Research Award: Melphalan toxicity and genetic polymorphisms.
    26, p. e114 2006
  • Pharmacotherapy
    Foral PA, Malesker MA, McPhillips AC, Christensen KJ, Hilleman DE. A time-motion analysis of tight glycemic control protocols in the intensive care unit.
    26, p. e58 2006
  • American Journal of Pharmaceutical Education
    Christensen KJ, Boyd ST. Utilizing PDA technology to assess student-patient encounters.
    70(3), p. 65 2006
  • ASHP Midyear Clinical Meeting
    Christensen KJ, Ineck BA. Veteran compliance with formoterol therapy. ASHP Midyear Clinical Meeting
    40, p. P-387R 2005
  • American Journal of Pharmaceutical Education
    Christensen KJ, Monaghan MS. Evidence of potential deficiency in longitudinal learning: Pharmacy calculations.
    67(3), p. 100 2003
  • American Journal of Pharmaceutical Education
    Stowe CD, Gardner SF, Christensen KJ. Standardized patient examination scores are useful in identifying students most in need of remediation.
    66, p. 94s 2002
  • ASHP Midyear Clinical Meeting
    Williams Y, Christensen KJ. Retrospective analysis characterizing the pharmacokinetic monitoring of outpatient aminoglycoside therapy in a cystic fibrosis population. ASHP Midyear Clinical Meeting
    36, p. P-46R 2001
  • ASHP Midyear Clinical Meeting
    Thomas M, Christensen KJ, Warmack TS, McConnell SA. Retrospective review of community-acquired pneumonia patients receiving warfarin: focusing on changes in INR. ASHP Midyear Clinical Meeting
    36, p. p-266r 2001
  • ASHP Midyear Clinical Meeting
    Christensen KJ. Impact of a growing cystic fibrosis population on antibiotic sensitivities for Pseudomonas aeruginosa.
    35, p. P-428R 2000

Presentations

  • Asthma Management: Pharmacological Therapy. Asthma Educator Institute (CE PROGRAM), Omaha, NE, July 2014. 2014
  • Development of an Interactive Electronic Health Record as a Training Tool for Pharmacy Students. Wide-River TEC Conference (CE PROGRAM), Lincoln, NE, September 2011. 2011
  • Exam Writing Seminar; Creighton University School of Pharmacy and Health Professions, January, 2010. 2010
  • The Rules of Engagement. Creighton University School of Pharmacy and health Professions School Retreat, January 2010. 2010
  • Christensen KJ. Teaching with technology: A pharmacy resident certificate program. 110th Annual Meeting of the American Association of Colleges of Pharmacy, Boston, MA; July 2009. 2009
  • Exam Writing Seminar; Creighton University School of Pharmacy and Health Professions, January, 2009. 2009
  • Updated Strategies for Asthma Treatment; Creighton University School of Pharmacy and Health Professions Alumni Weekend, October 2008. (CE PROGRAM) 2008
  • Updated Strategies for Asthma Treatment; Midwest College of Clinical Pharmacy Winter Meeting, November 2008. (CE PROGRAM) 2008
  • Update on Pulmonary Hypertension Treatment. VA Pharmacy Grand Rounds Presentation, VA-NWI Medical Center, October 2007. (CE PROGRAM) 2007
  • Liver Failure & Drugs. Department of Internal Medicine – GI Division, Creighton University Medical Center, Omaha, NE. March 2005. 2005
  • Primary Pulmonary Hypertension Review. Department of Pharmacy Practice Grand Rounds, October 2004. (CE PROGRAM) 2004
  • Christensen KJ, Monaghan MS. Evidence of potential deficiency in longitudinal learning: pharmacy calculations. 104th Annual Meeting of the American Association of Colleges of Pharmacy, Minneapolis, MN; July 2003. (Poster presentation) 2003
  • Severe Sepsis Diagnosis & Treatment. Hot Springs Physician and Pharmacist Group, Hot Springs, AR, February 2002. 2002
  • Treatment of Sepsis with Drotrecogin Alfa; Beaumont Oncology/CCN Nurse Group, Beaumont, TX, January 2002 2002
  • Treatment of Sepsis with Drotrecogin Alfa; Beaumont Pharmacist and Nurse Group, Beaumont, TX, December 2001 2001
  • Treatment of Sepsis with Drotrecogin Alfa; Northeast Louisiana Association of Health-System Pharmacists, Monroe, LA, November 2001. 2001
  • New Insights on the Treatment of Sepsis; Pine Bluff Pharmacist and Physician Group, Pine Bluff, AR, November 2001 2001
  • New Insights on the Treatment of Sepsis; Lake Charles Pharmacy Group, Lake Charles, LA, November 2001 2001
  • New Insights on the Treatment of Sepsis; Southern Region Critical Care Nurses Association, Lafayette, LA, October 2001 2001
  • Update on Sepsis Treatment. Little Rock Pharmacist Group, Little Rock, AR, September 2001. (CE PROGRAM) 2001
  • New Insights on the Treatment of Sepsis; Arkansas Association of Critical Care Nurses, Little Rock, AR, August 2001. (CE PROGRAM) 2001
  • New Insights on the Treatment of Sepsis; Mid-South College of Clinical Pharmacy, Little Rock, AR, June 2001. (CE PROGRAM) 2001
  • Christensen KJ. Impact of a growing cystic fibrosis population on antibiotic sensitivities for pseudomonas aeruginosa. ASHP Midyear Clinical Meeting, Las Vegas, NV; December 2000. (Poster Presentation) 2000
  • CAP & AECB (review). Physician/Pharmacy Grand Rounds, AHEC Northeast, Jonesboro, AR, October 2000. (CE PROGRAM) 2000
  • Christensen KJ, Parr MD, Thannisch RW, Smith CW. Implementing a monitored drug program using physician order entry. Arkansas Association of health Systems Pharmacists Fall Seminar, Eureka Springs, AR; September 2000. (Poster Presentation) 2000
  • Gubbins PO, Christensen KJ, Crouse KL, Hoffman K, Bradsher RW. A prospective surveillance of antibiotic susceptibilities of gram negative isolates from the intensive care units of a university hospital. ACCP Annual Meeting, Orlando, FL; February 1995. 1995
  • Christensen KJ, Rospond RM. Correlation between obesity and stage of breast cancer at first diagnosis: A retrospective study. ASHP Midyear Clinical Meeting, Atlanta, GA; December 1993. (Poster Presentation) 1993

Industry/Corporation

  • “Retrospective Investigation of the Comparative Effectiveness of Daptomycin vs Vancomycin for the Treatment of MRSA Bacteremia with Vancomycin MICs of 1.5 – 2.0 µg/mL (MASS).” Cubist Pharmaceuticals, Inc., $10,250, funded, Investigator, October 2011 to April 2013.

  • “Insulin Infusion Protocols in the ICU: An Efficiency Evaluation.” LifeScan, $50,940 ($11,250 Stipend), Funded, Co-investigator, December 1, 2005 to March 31, 2006.

Other

  • “Development of an Interactive Electronic Health Record as a Training Tool for Pharmacy Students.” Wide River TEC EHR Curriculum Development Award, $3,000, funded, Co-Investigator, February 2011 to December 2011.

  • “Use of a Simulated Electronic Medical Record in Pharmacotherapeutics Case Study.” 2007 Innovations Grant Program, Creighton University, $3,450, funded, Co-investigator, November 1, 2007 to May 31, 2008.

  • Utilizing PDA Technology to Assess Student-Patient Encounters. 2004 Summer Assessment Grant Program, Creighton University, $6,846.00, Funded, Co-investigator, January 1, 2004 to December 31, 2004.

Awards

  • "Teacher of the Year" March 2011
    from the Campus Class of 2011, Creighton University School of Pharmacy & Health Professions.
  • "Excellence in Leadership Award" November 2009
    from the Phi Lambda Sigma National Leadership Society, Alpha Mu Chapter, Creighton University School of Pharmacy & Health Professions.
  • "Excellence in Teaching Award" February 2009
    from the Rho Chi Honor Society, Alpha Alpha Chapter, Creighton University School of Pharmacy & Health Professions.
  • "Excellence in Leadership Award" October 2007
    from the Phi Lambda Sigma National Leadership Society, Alpha Mu Chapter, Creighton University School of Pharmacy & Health Professions.
  • "Teacher of the Year" March 2007
    from the Campus Class of 2007, Creighton University School of Pharmacy & Health Professions.
  • "Teacher of the Year" April 2006
    from the Campus Class of 2007, Creighton University School of Pharmacy & Health Professions.
  • "Excellence in Teaching Award" February 2006
    from the Rho Chi Honor Society, Alpha Alpha Chapter, Creighton University School of Pharmacy & Health Professions.
  • "Excellence in Leadership Award" October 2005
    from the Phi Lambda Sigma National Leadership Society, Alpha Mu Chapter, Creighton University School of Pharmacy & Health Professions.
  • "Hospital Pharmacist Manager of the Year" October 1998
    from the Arkansas Association of Health-System Pharmacists.